, Tracking Stock Market Picks
Enter Symbol:
Neurocrine Biosciences, Inc. (NBIX) [hlAlert]

up 37.88 %

Neurocrine Biosciences, Inc. (NBIX) rated Outperform with price target $40 by Robert W. Baird

Posted on: Thursday,  Feb 5, 2015  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Neurocrine Biosciences, Inc. (NASDAQ: NBIX) on 02/05/2015, when the stock price was $33.55.
Since then, Neurocrine Biosciences, Inc. has gained 37.88% as of 10/12/2015's recent price of $46.26.
If you would have followed this Robert W. Baird's recommendation on NBIX, you would have gained 37.88% of your investment in 249 days.

Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/5/2015 8:25 AM Buy
33.55 40.00
as of 8/27/2015
1 Week down  -0.45 %
1 Month down  -5.08 %
3 Months up  10.30 %
1 YTD up  37.88 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy